SAN FRANCISCO, Oct. 9, 2014 /PRNewswire/ -- Strand Life Sciences (Strand) representatives will demonstrate new capabilities of the company's next-generation sequencing data software, Strand NGS at the 64th Annual Meeting of The American Society of Human Genetics (ASHG) to be held from Oct. 18th to 22nd in San Diego, California. The meeting will feature invited presentations by the world's leading geneticists, workshops and sessions about new developments in basic, translational, and clinical human genetics research and technology. At ASHG, Strand will highlight new features in Strand NGS such as the enhanced SNP and copy number detection workflows and multi-omic analyses.
The Strand NGS 2.1 release introduces custom SNP filters in the SNP detection workflow to filter out potentially false positive variants. It also provides the ability to create coverage profiles that store the basic coverage statistics for each target region of interest, a benefit to Copy Number Variation (CNV) workflows. "These profiles can be readily used in the CNV workflow as a reference to detect copy number variations. These enhancements reflect Strand's continued commitment to develop new and better methods for NGS data analysis," says Dr. Rohit Gupta, Head, NGS Application Science, Strand.
"I have used Strand NGS for more than two years and have seen it significantly increase my lab's productivity. From small RNA-Seq, ChIP-Seq, and targeted RNA-Seq, through whole-transcriptome, whole-methylome, and even whole-genome analyses, there are so many features, workflows and tools available that it literally takes the work out of NGS analysis. There is no other NGS analysis product, commercial or otherwise, that can do so many things this well, and they are continually adding more features in response to customer needs. I can't think of a better option for the biologist who wants to quickly and comprehensively analyze and understand their NGS data," says Frank A. Middleton, Associate Professor and Director, SUNY Upstate Medical University.
Strand NGS is developed on Strand's proprietary 'Avadis®' framework which powers high-throughput data analysis solutions used by more than 3,000 customers worldwide including top pharmaceutical companies, biotechnology organizations, research and academic institutions in over 40 countries. An enterprise version of Strand NGS (Server Edition) is also available and it allows multi-member teams to collaborate, share data, and speed up the analysis. At ASHG 2014, Strand will present five posters in the sessions on 'Bioinformatics and Genomic Technology' and 'Clinical Genetic Testing'. The posters highlight benchmarking studies and case studies performed at Strand. A schedule of these poster sessions is available on the Strand NGS website. Come meet Strand experts for a demonstration of the new Strand NGS features at ASHG Booth #338.
About Strand Life Sciences
Founded in 2000, Strand is a leader in technology innovations for healthcare using genomics. By enhancing sequence-based diagnostics and clinical genomic data interpretation using a strong foundation of computational, scientific, and medical expertise, Strand is bringing individualized medicine to the world.
SOURCE Strand Life Sciences